OBJECTIVE: To probe into the effects of terbutaline combined with budesonide aerosol inhalation in prevention of cough after influenza A

so as to evaluate the contribution of aerosol inhalation to the prevention of cough.METHODS: Totally 80 patients with influenza A（ without cough symptoms at admission） admitted into Feasured Medical Center of PAP from Nov. 1 st

2018 to Feb. 24 th

2019 were extracted to be divided into the routine treatment group and aerosol inhalation treatment group via the random number table

with 40 cases in each group. The routine treatment group was given routine treatment

while the aerosol inhalation treatment group received terbutaline combined with budesonide aerosol inhalation based on the routine treatment group. The incidence of cough

time of first occurrence and length of stay of two groups were statistically analyzed. RESULTS: The incidence of cough in the aerosol inhalation treatment group was 15. 00%（ 6/40）

significantly lower than 37. 50%（15/40） of the routine treatment group

and the difference was statistically significant（ P<0. 05）. The mean time of first occurrence and the mean length of stay in the aerosol inhalation treatment group were significantly shorter than those in the routine treatment group

with statistically significant differences（ P < 0. 05）. CONCLUSIONS: Terbutaline combined with budesonide aerosol inhalation can effectively reduce the incidence of cough in patients with influenza A.